Woodline Partners LP Portfolio Holdings

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Woodline Partners LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $11 Billion distributed in 586 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Meta Platforms, Inc. with a value of $242M, Gilead Sciences, Inc. with a value of $162M, Abb Vie Inc. with a value of $160M, Revolution Medicines, Inc. with a value of $156M, and Vaxcyte, Inc. with a value of $126M.

Examining the 13F form we can see an increase of $1.05B in the current position value, from $9.97B to 11B.

Woodline Partners LP is based out at San Francisco, CA

Below you can find more details about Woodline Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $11 Billion
Healthcare: $4.6 Billion
Technology: $2.09 Billion
Industrials: $883 Million
Financial Services: $722 Million
Energy: $697 Million
Consumer Cyclical: $646 Million
Communication Services: $630 Million
Consumer Defensive: $383 Million
Other: $371 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.25B
$601,000 0.01% of portfolio
10,674
Q3 2024 Reduced 85.51%
$6.47B
$1.45 Million 0.01% of portfolio
7,475
Q3 2024 New
$1.95B
$1.63 Million 0.01% of portfolio
439,818
Q3 2024 Added 0.45%
$667M
$845,000 0.01% of portfolio
94,223
Q3 2024 Reduced 0.44%
$24.9M
$986,000 0.01% of portfolio
684,805
Q3 2024 Reduced 57.01%
$5.78B
$1.15 Million 0.01% of portfolio
7,750
Q3 2024 New
$11.5B
$766,000 0.01% of portfolio
4,623
Q3 2024 Reduced 91.01%
$72.3M
$779,000 0.01% of portfolio
787,288
Q3 2024 Added 0.7%
$1.54B
$1.07 Million 0.01% of portfolio
31,373
Q3 2024 Added 25.17%
$22M
$1.49 Million 0.01% of portfolio
948,702
Q3 2024 Added 0.11%
$1.63B
$1.23 Million 0.01% of portfolio
27,001
Q3 2024 New
$29.1M
$1.56 Million 0.01% of portfolio
851,567
Q3 2024 Added 751.56%
$293M
$1.11 Million 0.01% of portfolio
67,259
Q3 2024 Reduced 10.32%
$3.13B
$901,000 0.01% of portfolio
31,039
Q3 2024 Added 56.22%
$3.67T
$883,000 0.01% of portfolio
3,792
Q3 2024 Reduced 0.76%
$270M
$1.57 Million 0.01% of portfolio
1,091,000
Q3 2024 Reduced 56.4%
$626M
$1.25 Million 0.01% of portfolio
111,660
Q3 2024 Added 7.76%
$5.9B
$249,000 0.0% of portfolio
19,494
Q3 2024 New
$226M
$66,000 0.0% of portfolio
11,294
Q3 2024 New
Waystar Hldg Corp
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 15.68%
Twfg Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Abivax Sa
-
$0 0.0% of portfolio
-
Q3 2024 Added 161.25%
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 20.94%
Ardent Health Partners Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$409M
$288,000 0.0% of portfolio
23,274
Q2 2024 Reduced 90.04%
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 82.01%
$100M
$540,000 0.0% of portfolio
108,584
Q3 2024 Reduced 33.58%
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 Added 14.46%
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 0.76%
$69B
$235,000 0.0% of portfolio
165
Q3 2024 Reduced 85.91%
Birkenstock Holding PLC
-
$0 0.0% of portfolio
-
Q3 2024 Added 0.45%
Zura Bio LTD
-
$0 0.0% of portfolio
-
Q3 2024 Added 0.53%
$453M
$108,000 0.0% of portfolio
18,529
Q3 2024 New
$2.45B
$350,000 0.0% of portfolio
19,190
Q3 2024 New
$410M
$394,000 0.0% of portfolio
53,347
Q3 2024 New
Webtoon Entmt Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 0.14%
$0
$0 0.0% of portfolio
986,007
Q3 2024 Added 250.71%
Bioage Labs Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Bicara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Arm Holdings PLC
-
$0 0.0% of portfolio
-
Q3 2024 New
$2.13B
$203,000 0.0% of portfolio
25,122
Q3 2024 New
$1.08T
$204,000 0.0% of portfolio
1,221
Q3 2024 Reduced 1.37%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q3 2024 Added 12.15%
$276M
$346,000 0.0% of portfolio
103,358
Q3 2024 New
Alto Neuroscience Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
$4.71B
$400,000 0.0% of portfolio
1,704
Q3 2024 New
$2.15T
$427,000 0.0% of portfolio
2,296
Q3 2024 Reduced 98.8%
$504B
$215,000 0.0% of portfolio
784
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 586
  • Current Value $11 Billion
  • Prior Value $9.97 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 203 stocks
  • Additional Purchases 219 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 152 stocks
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email